US Supreme Court backs ‘rule-of-reason’ for pay-for-delay
A majority of the US Supreme Court has ruled that the US Federal Trade Commission (FTC) should be able to challenge so-called ‘pay-for-delay’ patent litigation settlements on antitrust grounds.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
25 July 2013 The chair of the Federal Trade Commission has said it will continue to challenge pay-for-delay court settlements in the pharmaceutical industry and has hailed a Supreme Court ruling as a victory for consumers.
20 June 2013 The European Commission’s competition directorate has levied fines totalling €146 million ($195 million) against originator pharmaceutical company Lundbeck and several producers of generics drugs.
1 March 2013 The US Federal Trade Commission has confirmed that President Barack Obama will appoint commissioner Edith Ramirez as chair of the agency following the departure of Jon Leibowitz.
